CEACAM5 and colorectal carcinoma: Fluorescence-guided surgery (FGS) with anti-CEA fluorescent antibodies led to improved rates of R0 resection in a CRC PDOX model [21] and increased disease-free survival (DFS) and overall survival (OS) [22].